Automation in new frontiers of bioanalysis: a key for quality and efficiency
Bringing new technologies into regulatory space
Amplion Research launches first comprehensive biomarker database
Ezose Sciences announce partnership with Fast Forward
Agenix advance their diagnostics pipelines through agreements with Tyrian
MicroConstants undergo routine inspection by US FDA
Astute Medical Inc. develop Nephrocheck™ test for critically ill patients
Conference Report: The 3rd EBF Focus Meeting: ‘Hatching’ – emerging technologies approaching the regulated bioanalysis laboratory
Conference Report: Drug Metabolism Discussion Group Short Meeting: microsampling – the next big thing
Simultaneous determination of metoprolol and α-hydroxymetoprolol in human plasma using excitation–emission matrix fluorescence coupled with second-order calibration methods
Automated dried blood spots standard and QC sample preparation using a robotic liquid handler
Analysis of losartan and carvedilol in urine and plasma samples using a dispersive liquid–liquid microextraction isocratic HPLC–UV method
Evaluation of glucuronide metabolite stability in dried blood spots
Investigation of basic mobile phases with positive ESI LC–MS for metabonomics studies
Development and validation of an ultra-sensitive method for the measurement of plasma renin activity in human plasma via LC–MS/MS
MS-based approaches to unravel the molecular complexity of proprotein-derived biomarkers and support their quantification: the examples of B-type natriuretic peptide and apelin peptides
Acknowledgements